Nocardia: Difference between revisions

From IDWiki
Nocardia
No edit summary
No edit summary
 
(7 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{DISPLAYTITLE:''Nocardia'' species}}
[[Category:Gram-positive bacilli]]

==Background==
==Background==


===Microbiology===
===Microbiology===


*Beaded [[Stain::Gram-positive]] [[Stain::partially acid-fast]] [[Shape::bacillus]]
*Beaded [[Stain::Gram-positive]] [[Stain::partially acid-fast]] [[Shape::bacillus]] within the class [[Class::Actinobacteria]] and order [[Order::Corynebacteriales]]
*Catalase [[Catalase::positive]] and lyzozyme resistant
*Has a classic beaded branching cell morphology
*Microscopic appearance similar to [[Actinomyces]], differentiated by acid fast staining ([[Actinomyces]] is ''not'' acid fast)
*Colonies are slow to grow and have a chalky white appearance
*Ubiquitous environmental saprophyte found in soil and water

=== Pathophysiology ===

* Spores or mycelia are either inhaled into the lungs or directly inoculated in the skin and soft tissue
* Traumatic inoculation includes during motor vehicle collisions, mild scratches or pricks, or nosocomial with dirt entering through an open wound or central line
* Forms difficult-to-treat biofilms when involved in [[CLABSI|CLABSIs]]

=== Risk Factors ===

* More common in immunocompromised (cell-mediated immunodeficiency including [[HIV]], hematologic malignancy, and transplant patients), though can also occur in immunocompetent who have [[COPD]], [[bronchiectasis]], and [[cystic fibrosis]]
* Among transplant recipients, [[lung transplant]] appears to be highest risk
* High-dose steroids and high levels of [[calcineurin inhibitors]] appear to be specific risk factors
* Also diabetes and alcohol use

== Clinical Manifestations ==

=== Primary Cutaneous ===

* Typically acquired by direct inoculation with soil
* [[Nocardia brasiliensis]] is the most common cause in North America
* May present with superficial soft tissue infection, including ulcer, abscess, cellulitis, pustules, plaques, or papules, most commonly on the arms and legs
* Can progress to lymphocutaneous infection with [[sporotrichoid lesions]]

=== Pulmonary ===

* Subacute or chronic cough, dyspnea, fever, with or without pleuritic chest pain
* Most common form of disease in US
* Colonization also possible, particularly with patients who have structural lung changes like [[cystic fibrosis]]
* Starts with inflammation followed by formation of granulomas and necrotic abscesses
* Imaging typically showed lung nodules, lobar consolidation, and pleural effusion, and may show infiltrates and necrotizing granulomas
** Usually bilateral
** Cavitations more common in immunocompromised patients

=== Disseminated ===

* Usually starts with a focal infection (skin or lung), which then disseminates hematogenously
* Most commonly involves skin, lungs, and CNS, but can also disseminate to kidney, joint, retina, and heart
* Much more common in immunosuppressed patients

=== CNS Disease ===

* Most common site of hematogenous dissemination
* Presents with typical symptoms of fever, headache, meningismus, seizure, and focal neurologic deficits
* Can also be asymptomatic, so immunocompromised patients should get imaging and possibly LP

=== Other ===

* [[Mycetoma]]
* [[Bacteremia]]
* Ocular infection, either from direct inoculation or hematogenous spread
* Bone and joint infection, primarily from dissemination


==Management==
==Management==


=== Further Evaluation ===

* Consider screening MRI brain in all patients with disseminated or pulmonary disease regardless of neurologic symptoms
* Consider CT chest in all patients
* Consider assessment for immunodeficiency; at the very least, HIV testing and a good history

=== Antimicrobial Selection ===
*Mild to moderate: [[Is treated by::TMP-SMX]]
*Mild to moderate: [[Is treated by::TMP-SMX]]
**Immunocompetent: 5-10 mg/kg split tid to qid
**Immunocompetent: 5-10 mg/kg split tid to qid
Line 22: Line 82:
* Serious pulmonary infection: 6 to 12 months or longer
* Serious pulmonary infection: 6 to 12 months or longer
* Any non-cutaneous disease in immunocompromised host: at least 12 months, and possibly lifelong suppression
* Any non-cutaneous disease in immunocompromised host: at least 12 months, and possibly lifelong suppression

=== Monitoring ===

* Serial CT scans to assess response to therapy
* Monitoring for antibiotic toxicity{{DISPLAYTITLE:''Nocardia''}}
[[Category:Gram-positive bacilli]]

Latest revision as of 22:05, 12 March 2023

Background

Microbiology

  • Beaded Gram-positive partially acid-fast bacillus within the class Actinobacteria and order Corynebacteriales
  • Catalase positive and lyzozyme resistant
  • Has a classic beaded branching cell morphology
  • Microscopic appearance similar to Actinomyces, differentiated by acid fast staining (Actinomyces is not acid fast)
  • Colonies are slow to grow and have a chalky white appearance
  • Ubiquitous environmental saprophyte found in soil and water

Pathophysiology

  • Spores or mycelia are either inhaled into the lungs or directly inoculated in the skin and soft tissue
  • Traumatic inoculation includes during motor vehicle collisions, mild scratches or pricks, or nosocomial with dirt entering through an open wound or central line
  • Forms difficult-to-treat biofilms when involved in CLABSIs

Risk Factors

  • More common in immunocompromised (cell-mediated immunodeficiency including HIV, hematologic malignancy, and transplant patients), though can also occur in immunocompetent who have COPD, bronchiectasis, and cystic fibrosis
  • Among transplant recipients, lung transplant appears to be highest risk
  • High-dose steroids and high levels of calcineurin inhibitors appear to be specific risk factors
  • Also diabetes and alcohol use

Clinical Manifestations

Primary Cutaneous

  • Typically acquired by direct inoculation with soil
  • Nocardia brasiliensis is the most common cause in North America
  • May present with superficial soft tissue infection, including ulcer, abscess, cellulitis, pustules, plaques, or papules, most commonly on the arms and legs
  • Can progress to lymphocutaneous infection with sporotrichoid lesions

Pulmonary

  • Subacute or chronic cough, dyspnea, fever, with or without pleuritic chest pain
  • Most common form of disease in US
  • Colonization also possible, particularly with patients who have structural lung changes like cystic fibrosis
  • Starts with inflammation followed by formation of granulomas and necrotic abscesses
  • Imaging typically showed lung nodules, lobar consolidation, and pleural effusion, and may show infiltrates and necrotizing granulomas
    • Usually bilateral
    • Cavitations more common in immunocompromised patients

Disseminated

  • Usually starts with a focal infection (skin or lung), which then disseminates hematogenously
  • Most commonly involves skin, lungs, and CNS, but can also disseminate to kidney, joint, retina, and heart
  • Much more common in immunosuppressed patients

CNS Disease

  • Most common site of hematogenous dissemination
  • Presents with typical symptoms of fever, headache, meningismus, seizure, and focal neurologic deficits
  • Can also be asymptomatic, so immunocompromised patients should get imaging and possibly LP

Other

  • Mycetoma
  • Bacteremia
  • Ocular infection, either from direct inoculation or hematogenous spread
  • Bone and joint infection, primarily from dissemination

Management

Further Evaluation

  • Consider screening MRI brain in all patients with disseminated or pulmonary disease regardless of neurologic symptoms
  • Consider CT chest in all patients
  • Consider assessment for immunodeficiency; at the very least, HIV testing and a good history

Antimicrobial Selection

Duration

  • Isolated cutaneous infection in immunocompetent host: 3 to 6 months
  • Isolated cutaneous infection in immunocompromised host: 6 to 12 months
  • Serious pulmonary infection: 6 to 12 months or longer
  • Any non-cutaneous disease in immunocompromised host: at least 12 months, and possibly lifelong suppression

Monitoring

  • Serial CT scans to assess response to therapy
  • Monitoring for antibiotic toxicity